Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $7.0150 (1.96%) ($7.0150 - $7.0150) on Thu. Nov. 2, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.46% (three month average) | RSI | 48 | Latest Price | $7.0150(1.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT advances 1.5% a day on average for past five trading days. | Weekly Trend | EDIT declines -1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(78%) XBI(78%) ARKK(67%) IBB(65%) IBUY(65%) | Factors Impacting EDIT price | EDIT will decline at least -1.73% in a week (0% probabilities). TBT(-23%) VXX(-17%) UUP(-12%) VIXM(-5%) USO(3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.73% (StdDev 3.46%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $6.63(5.81%) | 10 Day Moving Average | $6.55(7.1%) | 20 Day Moving Average | $6.74(4.08%) | To recent high | -24.4% | To recent low | 12.1% | Market Cap | $436m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |